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Abstract
Background
Preterm and small for gestational age (SGA) births have been associated with adverse out-
comes during the first stages of life. We evaluated the morbidity and mortality associated
with preterm and SGA births during the first year of life in a rural area of Southern
Mozambique.
Methods
This is a retrospective cohort study using previously collected data from children born at the
Manhic¸a District Hospital in two different periods (2003–2005 and 2010–2012). Newborns
were classified as being preterm and/or SGA or as babies not fulfilling any of the previous
conditions (term non-SGA). All children were followed up for a year for morbidity and mortal-
ity outcomes.
Results
A total of 5574 live babies were included in the analysis. The prevalence of preterm delivery
was 6.2% (345/5574); the prevalence of SGA was 14.0% (776/5542) and 2.2% (114/5542)
of the children presented both conditions. During the neonatal period, preterm delivery and
SGA were associated with 13 (HR: 13.0, 95% CI 4.0–42.2) and 5 times (HR: 4.5, 95% CI:
1.6–12.6) higher mortality compared to term non SGA babies. Risk of hospitalization was
only increased when both conditions were present (IRR: 3.5, 95%CI: 1.5–8.1). Mortality is
also increased during the entire first year, although at a lower rate.
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Conclusions
Neonatal and infant mortality rates are remarkably high among preterm and SGA babies in
southern Mozambique. These increased rates are concentrated within the neonatal period.
Prompt identification of these conditions is needed to implement interventions aimed at
increasing survival of these high-risk newborns.
Introduction
Preterm birth is the world’s leading cause of death in children under five years[1]. It has been
estimated that each year, 11% of all deliveries in the world are premature, and one million out
of six million child deaths are due to complications of prematurity[2,3]. Small for gestational
age (SGA) births, are also a prevalent condition among newborns from low and middle
income countries (up to 27% of all deliveries are SGA), with higher prevalence in South East
Asia and Sahelian countries[4]. Preterm and SGA births are associated with adverse health
consequences, including increased neonatal and infant mortality, childhood malnutrition,
visual and hearing problems, and adulthood metabolic disease[5,6].
Both preterm birth and SGA are intrinsically associated with low birth weight and are not
mutually exclusive. On the one hand, preterm birth is associated with multiple maternal and/or
foetal conditions, including maternal and neonatal infections, vascular disease, uterine overdis-
tension, pre-eclampsia/eclampsia or intrauterine growth restriction (IUGR)[7]. On the other
hand, SGA is frequently associated with disorders such as foetal genetic/chromosomal defects or
also to IUGR[8]. The latter is associated with factors that prevent normal circulation across the
placenta causing poor nutrient and oxygen supply to the foetus, including maternal undernutri-
tion, anemia, malaria, HIV and other acute or chronic infections[9]. Alternatively, SGA can
result from an incorrect assessment of gestational age or a constitutionally–albeit not necessarily
pathological- small size. However, since preterm and SGA babies are at risk of presenting differ-
ent health problems they are associated with different morbidity and mortality risks[10]. Com-
pared to SGA, preterm babies have been associated with higher risk of death during infancy, but
lower risk of morbidity and better growth patterns during the first two years of life[10].
Despite the relative high prevalence and adverse outcomes associated with preterm births
and SGA in low-income settings, very few studies have assessed their impact on neonatal and
infant mortality and morbidity in sub Saharan Africa. Only one longitudinal study conducted
in Malawi showed that preterm birth was associated with a greater risk of death as well as
growth and development disabilities[11]. Understanding the true impact of these two common
conditions is essential to improve pregnancy management and prevent their consequences in
low income settings. Importantly, those regions with high rates of preterm births and low
birth weight, mainly South East Asia and Africa, are also those with most fragile and underfi-
nanced health programs, increasing the difficulties to tackle this health problem[12]. The main
objective of this study was to evaluate the morbidity and mortality associated with preterm
and SGA births during infancy in a rural area of Southern Mozambique.
Methods
Study setting
The study was conducted at the Centro de Investigacão em Sau´de da Manhic¸a (CISM) in the
District of Manhic¸a, a malaria endemic semi-rural area in Southern Mozambique. The CISM
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is adjacent to the Manhic¸a District Hospital (MDH) and runs a demographic surveillance sys-
tem (DSS) covering 90000 inhabitants in 2010 in what constitutes the study area. A passive
case detection system is also running at the HDM that covers all paediatric outpatient visits
and admissions. More than 80% of the deliveries in the district are institutional[13]. The preva-
lence of HIV infection detected through the antenatal clinic (ANC) has steadily increased in
recent years, ranging from 23.6% in 2003–2004[13] to 29.4% in 2010[14]. Infant and neonatal
mortality rates varied from 83.9 and 26 in 2004 to 63.0 and 240 per 1000 live births in 2010
(Nhacolo A., Charfudin et al personal communication)[15]. Other health and demographic
characteristics of the population of the district have been described elsewhere[16].
Study design
This is a retrospective cohort study of collected data from children born at the MDH in two
different time periods; period 1: from August 2003 to April 2005 and period 2: form March
2010 to March 2012. During these periods, gestational age was routinely captured for all births
taking place at the MDH, due to the coexistence of research studies which required the assess-
ment of gestational age. Infants were classified as being preterm and/or SGA, or as babies not
fulfilling any of the previous conditions (term, non-SGA). All babies were followed up for a
year for morbidity and mortality outcomes using the hospital passive case detection system
and the DSS. Inclusion criteria for this analysis included living in the study area, being a live
birth, being institutionally delivered, and having the gestational age and weight assessed at
birth.
Gestational age was evaluated using two different methods based on postnatal examination
of the newborn, namely, the Dubowitz test[17] (period 1) and the Ballard score[18] (period 2).
Both methods are based on clinical assessment that includes neurological criteria on the infant’s
maturity and other external physical criteria. Both methods are widely used in low-income
countries, where ultrasound examination is not readily available. Dubowitz and Ballard’s tests
were used in Manhic¸a due to the requirements of two different clinical trials evaluating antima-
larials for prevention of malaria in pregnancy, which took place in those previously mentioned
time periods[13,19,20]. Relevant socio-economic and demographic characteristics of the house-
holds of children included in the study are also recorded through the DSS.
Case definitions and statistical methods
Neonatal mortality was defined as the death of a live born baby within the first 28 complete
days after birth, and infant mortality as deaths occurring during the first 12 months of life. The
post-neonatal period was defined as that comprised after day 28 and the last day of the first
year of life (included). Preterm birth was defined as that occurring before the completion of 37
weeks of pregnancy. Low birth weight was defined as less than 2500 grams at birth[21]. Small-
for-gestational-age (SGA) was defined as birth weight below the 10th percentile for babies of
the same gestational age[5]. Since no reference birthweight charts per percentile are available
for the Mozambican population, we used as reference birthweights from a recent large study
in HIV negative babies from Botswana[22].
Only live born babies (single and multiple deliveries) were included in this analysis. Inci-
dence of outpatient visits or hospitalizations and mortality rates were calculated using time at
risk from date of birth until date at one year of age, death or withdrawal. Mortality rates are
expressed per 1000 children years at risk (CYAR). Association between risk factors and occur-
rence of any of the conditions at delivery was evaluated using univariate and multivariable
logistic regression models. Hazard Ratio (HR) of mortality among different cohorts was evalu-
ated using Cox Regression Models adjusted for child sex, HIV status of the mother, number of
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previous pregnancies, maternal age, period and socio economic status (SES). Incidence rate
ratio (IRR) of outpatient clinic visits or hospitalizations was assessed using negative binomial
regression due to the possibility of several episodes during the study period. Variables for the
multivariate analysis in the logistic, Cox, and negative binomial regression models were
selected using the forward-stepwise approach with a p-value lower than 0.1 (obtained through
likelihood ratio test). Multivariable models were estimated by a complete case analysis with
missing values removed. P values lower than 0.05 were considered statistically significant.
SES was calculated using Principal Component Analysis (PCA) following the methodology
described elsewhere[23]. The families of the children were grouped into quintiles based on the
SES rank.
All data were captured in handwritten CRFs and then double entered by data clerks into
the OpenClinica software. Data analysis was performed using Stata 13 (Stata Corporation, Col-
lege Station, TX, USA). Microsoft Excel (Microsoft Office Package 13) was used for building
graphs and tables.
Ethical considerations
This study is a retrospective analysis of previously collected information. Many participants
were part of two research studies, whose protocols and informed consents were reviewed
and approved by the National Ethics Board in Mozambique and the Ethics Committee from
the Hospital Clinic of Barcelona (Spain)[13,19,20]. This specific study was approved by the
Ethics Committee Hospital Clinic of Barcelona (Spain). Mothers/caregivers of children partici-
pating in the research studies signed a written informed consent form prior to enrolment. The
study was conducted following the principles of the Declaration of Helsinki. The funding
sources had no role in any step of the study, including the decision to submit the paper for
publication.
Results
Prevalence of low birth weight, preterm delivery and SGA
A total of 5574 live babies with available data on gestational age were included in the analysis
(3189 in period 1 and 2385 in period 2). Around 51.4% (2853/5554) of the babies were male
and 29.0% (656/2265) were born to HIV infected mothers. Among all children included 26.6%
(1397/5256) were born to primigravidae, and 23.2% (1219/5256 to women with more than 4
previous pregnancies.
The prevalence of low birth weight (<2500 g) in our sample was 10.3% (572/5570), that of
very low birth weight (<1500 g) was 0.5% (29/5570), and the proportion of preterm delivery
was 6.2% (345/5574). The prevalence of SGA was 14.0% (776/5542); among the SGA, 11.9%
(662/5542) were at term SGA, while 2.1% (114/5542) of them fulfilled both definitions of pre-
term and SGA simultaneously. Nearly 4% [3.7% (205/5542)] of the infants were preterm but
not SGA. Baseline characteristics of the study participants are depicted in Table 1.
Being multigravidae and older age were each associated with lower likelihood of SGA. If the
mother had more than four previous pregnancies the odds of being SGA was 52% lower com-
pared to the odds of primigravidae women (OR: 0.48, 95% CI: 0.25–0.90). Female sex and
maternal HIV infection were also associated with being SGA (OR: 1.42 95% CI: 1.05–1.91 and
OR: 1.78, 95% CI: 1.27–2.50, respectively). Likewise, the same variables were associated with
preterm delivery, although without statistical significance in the multivariable model. Tables 2
and 3 show the results of the univariate and multivariable logistic regression analysis after
adjusting for potential confounders.
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Table 1. Baseline characteristics of participants included in the analysis. Columns are not mutually exclusive.
Total live
births*
Preterm n
(%)
Total live
births*
SGA n
(%)
Total live
births
Non preterm–non
SGA n(%)
Total live
births
Preterm & SGA
n(%)
Total 5574 345(6.2) 5542 776
(14.0)
5542 4561 (82.3) 5542 114 (2.2%)
Previous
pregnancies
Primigravidae 1397 107 (7.7) 1390 295
(21.2)
1390 1035 (74.5) 1390 41 (3.0)
1–4 previous
pregnancies
2640 147 (5.6) 2603 309
(11.8)
2623 2221 (84.7) 2623 41 (1.6)
>4 1219 59 (4.9) 1213 132
(10.0)
1213 1051 (86.4) 1213 23 (1.9)
Mother’s age
<20 1385 116 (8.4) 1373 300
(21.8)
1373 1007 (73.3) 1026 40 (2.9)
20–34 3290 166 (5.1) 3277 369
(11.3)
3277 2804 (85.6) 2466 52 (1.6)
>35 587 28 (4.8) 582 68 (11.7) 582 503 (86.4) 483 12 (2.1)
Gestational age
<37 345 NA 319 114
(35.8)
319 NA 319 114(35.8)
37–42 5222 NA 5216 661
(12.7)
5216 4555 (87.3) 5216 NA
> 42 7 NA 7 1 (14.3) 7 6 (82.3) 7 NA
Birthweight (mean)
<1500 29 20 (69.9) 24 24
(100.0)
24 0 (0.0) 24 15 (62.5)
1500–2500 572 201 (35.2 565 461
(81.6)
565 9 (1.6) 565 99 (17.6)
>2500 4969 123 (2.48) 4951 291 (5.9) 4951 4550 (91.9) 4951 0 (0.0)
Newborn Sex
Male 2853 158 (5.54) 2833 342
(12.1)
2833 2408 (85.0) 2833 58 (2.1)
Female 2701 184 (6.81) 2689 431
(16.0)
2689 2137 (79.5) 2689 54 (2.1)
Period
> 2003–2006 3189 187 (5.9) 3167 497
(15.7)
3167 2563(80.9) 3167 60 (1.9)
< 2009–2012 2385 158 (6.6) 2375 279
(11.8)
2375 377(84.1) 2375 54 (2.3)
Study participant
No 3156 205 (6.5) 3135 437
(13.9)
3135 2571 (82.0) 3135 60 (1.9)
Yes 2418 140 (5.8) 2407 339
(14.1)
2407 1990 (82.7) 2407 54 (2.2)
Mother’s HIV status
Uninfected 1609 97 (6.0) 1605 218
(13.6)
1605 1337 (83.3) 1605 43(2.7)
Infected 656 38 (5.8) 651 94 (14.4) 651 532 (81.7) 651 11 (1.7)
SES
Poorest 508 26 (5.1) 508 67 (13.2) 508 426 (83.9) 508 11 (2.2)
2nd quintile 495 30 (6.1) 492 60 (12.2) 492 413 (83.9) 492 8 (1.6)
3rd quintile 514 31 (6.1) 511 72 (14.1) 511 419 (82.0) 511 9 (1.8)
(Continued )
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Mortality associated with preterm delivery and SGA during infancy
The overall neonatal mortality rate associated with preterm delivery (not SGA) was 599.3 (95%
CI 224.9–1596.7) per 1000 CYAR and the infant mortality rate was 79.2 per 1000 CYAR (95%
CI 35.6–176.3). Among preterm newborns regardless of the SGA status, the rates were 980.2
(95% CI 542.8–1769.9) and 136.1 (95% CI 84.6–218.9), respectively. The overall neonatal mor-
tality rate among term SGA newborns was 289.0 (95% CI 137.8–606.1) and the infant mortality
rate was 55.1 (95% CI 33.2–91.4). Among SGA newborns regardless of preterm delivery, the
mortality rates were 427.5 (95% CI 242.8–752.7) and 76.6 per 1000 CYAR (95% CI 51.3–114.2)
for the neonatal and first year of life period. The presence of both conditions (SGA and pre-
term birth) boosted both neonatal and infant mortality rates to 1299.8 (95% 541.0–3122.9) and
218.3 (95% CI: 113.6–419.5) per 1000 CYAR, respectively (Table 4). No relevant differences
on mortality rates were observed by sex of the infant.
Cox regression analysis adjusted for relevant variables is presented in Table 4. Both preterm
birth and SGA conditions were independently associated with a higher hazard of dying during
the neonatal period and infancy. During the first 28 days, preterm-non SGA delivery was asso-
ciated with 13 times higher mortality rate (per unit time) compared to term deliveries not SGA
(HR: 13.0, 95% CI 4.0–42.2), and term SGA was associated with about 5 times higher mortality
rate (per unit time) when compared to the at term-non SGA group (hazard ratio 4.5 (95% CI:
1.6–12.6). The hazard of dying in the neonatal period for both preterm and SGA was higher
when coexisting with each other. Mortality rates were still increased in the postneonatal period
although of less magnitude, leading to lower hazard ratios associated to preterm and SGA
compared to term-non-SGA babies. The hazard of dying the first year of life for both preterm
and SGA was higher when coexisting with each other.
Morbidity associated with preterm delivery and SGA during infancy
The incidence rate (IR) of outpatient clinic attendance was similar for the cohort of preterm-
non SGA babies compared to that of babies born at term non-SGA, both in the neonatal and
in the post-neonatal period (IRR 1.4, 95% CI: 0.9–2.4 and IRR: 1.0, 95% CI: 0.8–1.3 respec-
tively). Likewise, there were no differences on outpatient attendances among term SGA new-
borns compared to those born at term non-SGA (Table 5). Most outpatient diagnoses in SGA
and preterm infants were related to respiratory infections (29.2% and 20.1% respectively) fol-
lowed by skin and conjunctivitis related visits (23.6% and 16.7%, respectively). However, no
differences in the proportion of these diagnoses were observed in comparison to the at term
non-SGA group.
With regard to neonatal hospitalizations, these were more frequent only in babies with both
conditions (IRR 3.5; 95% CI 1.5–8.1) compared to the term non-SGA group. The rate of hospi-
talizations was also increased during the entire first year of life in preterm (IRR: 1.7: 95% CI:
1.0–2.9) and preterm and SGA babies (IRR: 2.5; 95% CI: 1.4–4.5) (Table 6).
Table 1. (Continued)
Total live
births*
Preterm n
(%)
Total live
births*
SGA n
(%)
Total live
births
Non preterm–non
SGA n(%)
Total live
births
Preterm & SGA
n(%)
4th quintile 496 30 (6.1) 494 63 (12.8) 494 418 (84.6) 494 15 (3.0)
Wealthiest 503 22 (4.4) 500 56 (11.2) 500 432 (86.4) 500 9 (1.8)
NA: Not applicable.
* There were missing values for several variables. Those participants were not included in the analysis. The variable “mother’s HIV status” was only
available for 2265 of the 5574 children with available gestational age and for 2256 of the 5542 with known SGA status.
doi:10.1371/journal.pone.0172533.t001
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Discussion
This is one of the few studies carried out in sub-Saharan Africa evaluating the impact of both
prematurity and small for gestational age births on mortality and morbidity during the first
year of life. Information available on the health impact of these two conditions mostly focus on
the neonatal period and derives from high or middle income countries. These findings show
that neonatal and infant mortality rates are remarkably higher during the neonatal and post-
neonatal periods in both preterm and SGA babies compared to babies born at term and non
SGA. However, preterm birth is associated with even higher neonatal and infant mortality,
almost two fold, compared to SGA without prematurity. This information is fundamental to
guide preventive and management measures.
The analysis has been done using different statistical models in order to allow for different
but important interpretation of the results, namely, the evaluation of preterm and SGA births
Table 2. Univariate and multivariable analysis of factors associated with preterm birth.
Univariate Analysis Multivariate analysis
Total Preterm uOR (95% CI) p value* aOR (95% CI) p value^
n (%)
Newborn Sex
Male 2491 83 (3.3) 1.00 <0.001 0.055
Female 2258 121 (5.4) 1.64 (1.23–2.18) 1.70 (0.98–2.95)
Previous pregnancies
Primigravidae 1095 60 (5.5) 1.00 0.006 1.00 0.66
1–4 previous pregnancies 2314 93 (4.0) 0.72 (0.52–1.01) 0.76 (0.34–1.71)
>4 1081 30 (2.8) 0.49 (0.32–0.77) 0.60 (0.19–1.88)
Mother’s age
<20 1073 66 (6.2) 1.00 <0.001 1.00 0.154
20–34 2908 104 (3.6) 0.57 (0.41–0.78) 0.46 (0.21–1.04)
>35 514 11 (2.2) 0.33 (0.17–0.64) 0.31 (0.05–1.77)
Period
> 2003–2006 2670 107 (4.0) 1.00 0.260 1.00 0.40
< 2009–2012 2096 98 (4.7) 1.17 (0.89–1.55) 1.29 (0.71–2.35)
Study participant
No 2698 127 (4.7) 1.00 0.112 #
Yes 2068 78 (3.8) 0.79 (0.59–1.06)
Mother’s HIV status
Uninfected 1387 50 (3.6) 1.00 0.367 1.00 0.073
Infected 557 25 (4.5) 1.25 (0.76–2.05) 1.75 (0.95–3.21)
SES
Poorest 394 13 (3.3) 1.00 0.282 1.00 0.20
2nd quintile 454 21 (4.6) 1.42 (0.70–2.88) 1.50 (0.64–3.49)
3rd quintile 457 17 (3.7) 0.13 (0.54–2.36) 1.04 (0.42–2.58)
4th quintile 454 19 (4.2) 1.28 (0.62–2.63) 1.60 (0.68–3.74)
Wealthiest 428 9 (2.1) 0.62 (0.26–1.48) 0.55 (1.18–1.69)
*p value calculated through Wald Tests.
^p value calculated through LR test.
# variable excluded in the model due to high collinearity with mother’s HIV status.
uOR = unadjusted odds ratio.
aOR = adjusted odds ratio.
doi:10.1371/journal.pone.0172533.t002
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as independent conditions (model 1, main model), but also the evaluation of these conditions
without considering the presence of the other (model 2 and 3). Prematurity was associated
with almost a 13 and 4 fold-increased risk of dying during the neonatal and the postneonatal
period, respectively. Small for gestational age on the other hand, was associated with a lower
risk of death compared to preterm births in all models, in line with findings from other studies
[10,24]. Since SGA definition is based on a statistical approach, babies with SGA might or
might not be associated with a specific morbid condition during pregnancy, and they could be
considered healthy children having no adverse consequences or complications during infancy
[25].
Our results on mortality rates associated with preterm and SGA in the neonatal period are
in line with those published in a recent pooled country analysis for low and middle income
countries[26]. It has been reported that the mortality rate among preterm births is almost two
Table 3. Univariate and multivariable analysis of factors associated with small for gestational age (SGA).
Univariate Analysis Multivariate analysis
SGA uOR (95% CI) p value* aOR (95% CI) p value^
Total n (%)
Newborn Sex
Male 2692 284 (10.6) 1 <0.001 1 0.021
Female 2137 377 (15.0) 1.50 (1.27–1.76) 1.42 (1.05–1.91)
Previous pregnancies
Primigravidae 1289 254 (19.7) 1 <0.001 1 0.054
1–4 previous pregnancies 2489 368 (10.8) 0.49 (0.41–0.59) 0.65 (0.42–1.01)
>4 1160 109 (9.4) 0.42 (0.33–0.54) 0.48 (0.25–0.90)
Mother’s age
<20 1267 260 (20.5) 1 <0.001 1 0.016
20–34 3121 317 (10.6) 0.44 (0.37–0.52) 0.52 (0.34–0.82)
>34 559 56 (10.0) 0.43 (0.32–0.59) 0.63 (0.28–1.44)
Period
> 2003–2006 3000 437(14.6) 1 <0.001 1 0.061
< 2009–2012 2223 225(10.1) 0.66 (0.56–0.78) 0.75 (0.55–1.01)
Study participant
No 2948 377 (12.8) 1 0.779 #
Yes 2275 285 (12.5) 0.97 (0.83–1.15)
Mother’s HIV status
Uninfected 1512 175 (11.6) 1 0.219 1 0.001
Infected 615 83 (13.5) 1.19 (0.90–1.58) 1.78 (1.27–2.50)
SES
poorest 430 49 (11.4) 1 0.71 1 0.88
2nd quintile 487 54 (11.1) 0.90 (0.61–1.31) 1.03 (0.64–1.65)
3rd quintile 505 65 (12.9) 1.06 (0.74–1.53) 1.07 (0.67–1.73)
4th quintile 488 53 (10.9) 0.98 (0.68–1.43) 1.14 (0.71–1.84)
wealthiest 464 45 (11.2) 0.83 (0.56–1.23) 0.83 (0.50–1.38)
* p value calculated through Wald Tests.
^ p value calculated through LR test.
# variable excluded in the model due to high collinearity with mother’s HIV status.
uOR = unadjusted odds ratio.
aOR = adjusted odds ratio.
doi:10.1371/journal.pone.0172533.t003
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fold increased during the second year of life [11]. These results confirm that the increased risk
is mostly concentrated during the neonatal period as it has been described long time ago by
Barros and colleagues [10]. In the analysis (model 1) for the post-neonatal period (data not
shown) an increased mortality rate associated with preterm delivery or SGA is not observed.
However, when analysing these conditions without taking into account the presence of the
other (models 2 and 3), an increased mortality during the postneonatal period is observed
(around three fold for preterm and 1.8 fold for SGA babies). This apparent discrepancy could
be explained by the presence of confounding, that is, in the preterm group there are many
SGA babies, distorting the independent association of prematurity with mortality. Likewise,
the same confounded association would occur when estimating mortality among SGA babies.
Interestingly, the results on morbidity seem to be contradictory with the mortality findings.
It seems that neither prematurity nor SGA births are associated independently with higher
rates of hospitalization during the neonatal period compared to those term non-SGA. Model
1, only shows an increased risk of hospitalization when both are present (IRR 3.5, 95% CI: 1.5–
8.1), but not when they are analysed separately. Moreover, we did not observe an increased
Table 4. Mortality rates (deaths per 1000 CYAR) and hazard ratios (HR) of dying during the neonatal period and first year of life of different cohorts
analysed.
Subjects Deaths Time At Risk (CYAR) Mortality Rate (Deaths per 1000 CYAR and 95% CI) HR (95% CI) p-value*
MODEL 1
Neonatal Period
Term & non SGA 2336 21 193.9 108.3 (70.6, 166.1) 1 < 0.0001
Term SGA 296 7 24.2 289.0 (137.8, 606.1) 4.5 (1.6–12.6)
Preterm & non SGA 84 4 6.7 599.3 (224.9, 1596.7) 13.0 (4.0–42.2)
Preterm & SGA 53 5 3.9 1299.8 (541.0, 3122.9) 11.2 (3.0–42.1)
0–12 month Period
Term & non SGA 2341 64 2199.2 29.1 (22.8–37.2) 1 < 0.0001
Term SGA 296 15 272.2 55.1 (33.2–91.4) 1.9(0.9–3.8)
Preterm & non SGA 84 6 75.8 79.2 (35.6–176.3) 3.7 (1.5–9.6)
Preterm & SGA 53 9 41.2 218.3 (113.6–419.5) 8.9 (3.9–20.6)
MODEL 2
Neonatal Period
Non Preterm 2635 28 218.4 128.2 (88.5–185.7) 1 < 0.0001
Preterm 147 11 11.2 980.2 (542.8–1769.9) 10.8(4.6–25.3)
0–12 month Period
Non Preterm 2640 79 2474.4 31.9 (25.6–39.8) 1 < 0.0001
Preterm 147 17 124.9 136.1 (84.6–218.9) 5.8 (3.1–10.6)
MODEL 3
Neonatal Period
Non SGA 2420 25 200.6 124.6 (84.2–184.5) 1 0.0013
SGA 349 12 28.1 427.5 (242.8–752.7) 4.1 (1.7–9.6)
0–12 month Period
Non SGA 2425 70 2275.0 30.8 (24.3–38.9) 1 0.0016
SGA 349 24 313.5 76.6 (51.3–114.2) 2.5 (1.4–4.4)
HR: adjusted Hazard Ratio. Cox multivariable regression model adjusted for: child sex, HIV status of the mother, number of previous pregnancies, period,
mother age and socio economic status.
CYAR: children year at risk.
* P-value obtained through Wald tests.
doi:10.1371/journal.pone.0172533.t004
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risk of outpatient attendances in the preterm or SGA cohort for any of the periods. This could
be due to several reasons. First, small numbers of hospitalizations and outpatient visits in the
preterm and SGA cohorts might have hindered the chances of finding this association if it
does indeed exist. Second, morbidity due to mild conditions might be similar between the
groups, and increased morbidity risk might only be associated with severe conditions, which
might be best reflected when analysing hospitalization risk of both SGA and preterm delivery.
Third, in this area of southern Mozambique many children are first taken to the traditional
healer when they are sick. If the potential health problems associated with preterm and/or
SGA are severe, children might not be taken to the formal health system before they die. Thus,
morbidity surveillance based on outpatient or inpatient attendances might be an underesti-
mate of the true morbidity burden associated with these conditions.
These findings underscore the need to identify these conditions early enough in order to
implement interventions aimed at increasing the level of care, and ultimately survival. How-
ever, with currently available strategies, there is a broad room for improvement in the field of
prevention, which should focus in targeting the known risk factors, including: preconception
Table 5. Incidence Rates (IR) of outpatient visits per 1000 CYAR and Incidence Rate Ratios (IRR) of visiting the outpatient clinic during the neona-
tal period and first year of life of different cohorts analysed.
Subjects Outpatient visits Time At Risk (CYAR) IR (per 1000 CYAR) and 95% CI) aIRR (95% CI) p-value*
MODEL 1
Neonatal Period
non Preterm & non SGA 2336 447 193.9 2.3 (2.1–2.5) 1 0.5895
non Preterm & SGA 296 56 24.2 2.3 (1.8–3.0) 1.0 (0.7–1.4)
Preterm & non SGA 84 20 6.7 3.0 (1.9–4.6) 1.4 (0.9–2.4)
Preterm & SGA 53 10 3.9 2.6 (1.4–4.8) 1.1 (0.5–2.1)
0–12 month Period
non Preterm & non SGA 2341 7462 2199.2 3.4 (3.3–3.5) 1 0.6922
non Preterm & SGA 296 911 272.2 3.4 (3.1–3.6) 0.9 (0.8–1.1)
Preterm & non SGA 84 251 75.8 3.3 (3.0–3.8) 1.0 (0.8–1.3)
Preterm & SGA 53 155 41.2 3.8 (3.2–4.4) 1.1 (0.8–1.4)
MODEL 2
Neonatal Period
non Preterm 2600 7876 2256.1 3.5 (3.4–3.6) 1 0.6884
Preterm 134 411 113.7 3.6 (3.3–4.0) 1.0 (0.9–1.2)
0–12 month Period
Non Preterm 2640 8379 2474.4 3.4 (3.3–3.5) 1 0.5676
Preterm 147 443 124.9 3.6 (3.2–3.9) 1.1 (0.9–1.3)
MODEL 3
Neonatal Period
Non SGA 2420 467 200.6 2.3 (2.1–2.6) 1 0.9032
SGA 349 66 28.1 2.4 (1.9–3.0) 1.0 (0.7–1.3)
0–12 month Period
Non SGA 2425 7713 2275.0 3.4 (3.3–3.5) 1 0.5187
SGA 349 1066 313.5 3.4 (3.2–3.6) 1.0 (0.9–1.1)
aIRR: adjusted Incidence Rate Ratio. Negative binomial regression model adjusted for: child sex, HIV status of the mother, number of previous
pregnancies, mother age, period and socio economic status.
CYAR: children year at risk.
* P value obtained through Wald tests.
doi:10.1371/journal.pone.0172533.t005
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counselling and family planning; health education programs aimed at prevention, early diag-
nosis and treatment of infections before and during pregnancy; increased control of condi-
tions such as diabetes, hypertension, anaemia, before and during pregnancy; close monitoring
of nutritional status and mental health of the mother, as well as implementation of best prac-
tices in assisted reproduction (which includes training to all health care workers involved)[27].
Although in our setting the rate of induced labour before week 37 is negligible, other settings
should closely monitor and potentially reduced these practices, as well as rates of caesarean
section.
This study has several limitations. First, gestational age was measured through indirect
methods based on postnatal examination of the newborn (Dubowitz test, Ballard score).
Although both methods have been validated and are broadly used in low income countries
[28], the accuracy, agreement and reproducibility of these methods have been questioned[29].
The Dubowitz test might underestimate GA in SGA and term infants[30], although it could
also overestimate GA in very preterm infants (<33 weeks)[31]. Some assessments have also
questioned the accuracy of the Ballard score[29]. If any of the methods would underestimate
Table 6. Incidence Rates (IR) of hospitalizations (per 1000 CYAR) and incidence rate ratios (IRR) of being hospitalized during the neonatal period
and first year of life of different cohorts analysed.
Subjects Hospitalizations Time At Risk (CYAR) IR (per 1000 CYAR) and 95% CI) IRR (95% CI) p-value*
MODEL 1
Neonatal Period
non Preterm & non SGA 2336 113 193.9 0.6 (0.5–0.7) 1 0.0324
non Preterm & SGA 296 17 24.2 0.7 (0.4–1.1) 1.0 (0.6–2.0)
Preterm & non SGA 84 7 6.7 1.1 (1.2–4.5) 1.6 (0.6–4.5)
Preterm & SGA 53 9 3.9 2.3 (1.2–0.8) 3.5 (1.5–8.1)
0–12 month Period
non Preterm & non SGA 2341 507 2199.2 0.2 (0.2–0.3) 1 0.0082
non Preterm & SGA 296 74 272.2 0.3 (0.2–0.3) 1.2 (0.8–1.6)
Preterm & non SGA 84 20 75.8 0.3 (0.2–0.4) 1.7 (1.0–2.9)
Preterm & SGA 53 22 41.2 0.5 (0.4–0.8) 2.5 (1.4–4.5)
MODEL 2
Neonatal Period
non Preterm 2635 132 218.4 0.6 (0.5–0.7) 1 0.0176
Preterm 147 17 11.2 1.5 (0.9–2.4) 2.2 (1.2–4.4)
0–12 month Period
Non Preterm 2640 583 2474.4 0.2 (0.2–0.3) 1 0.0027
Preterm 147 45 124.9 0.4 (0.3–0.5) 1.9 (1-3-2.9)
MODEL 3
Neonatal Period
Non SGA 2420 120 200.6 0.6 (0.5–0.7) 1 0.2767
SGA 349 26 28.1 0.9 (0.6–1.4) 1.4 (0.8–2.3)
0–12 month Period
Non SGA 2425 527 2275.0 0.2 (0.2–0.3) 1 0.088
SGA 349 96 313.5 0.3 (0.3–0.4) 1.3 (1.0–1.8)
aIIR: adjusted Incidence Rate Ratio. Negative binomial regression model adjusted for: child sex, HIV status of the mother, number of previous pregnancies,
mother age, period and socio economic status.
CYAR: children year at risk.
* P value obtained through Wald tests.
doi:10.1371/journal.pone.0172533.t006
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the GA, the prevalence of preterm birth could be slightly overestimated and mortality and
morbidity rates underestimated in comparison to the at-term non SGA group. In addition, in
order to calculate gestational age, children had to survive the first hours of life and be hospital
delivered, thus some deaths occurring before gestational age was assessed were not included.
This would certainly underestimate the prevalence of prematurity and small for gestational age
(but also the mortality risk associated with these conditions). Lastly, the fact that mothers have
participated in a research study might have underestimated the true prevalence of preterm
birth in this setting. It could be thought that this could have also positively contributed to bet-
ter health outcomes in the first year of follow up. However, a majority of children with avail-
able prospective data belonged to the mentioned studies, thus, we believe our measures of
effect are not biased in those born from study participants. If so, our findings would represent
a conservative estimate of the true mortality and morbidity rates.
Conclusions
In conclusion, these results contribute to the evidence on the increased risk of mortality
and morbidity associated with preterm and small for gestational age births in rural Africa.
This increased risk is much higher for preterm births than for SGA without prematurity
and appears to be concentrated within the neonatal period. Routine assessment of birth
weight and gestational age at birth, and identification of these conditions should prompt inter-
ventions aimed at increasing the level of care among these high-risk newborns and improve
survival.
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